Adaptimmune Therapeutics PLC (ADAP)

1.08 -0.01 (-0.92%) USD  |  NASDAQ  |  Jun 02, 16:00
1.09 +0.01 (+0.93%) After-Hours: 20:00
More

Adaptimmune Therapeutics PLC Performance

Annual Total Returns Versus Peers

Loading chart...
Name
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
YTD
Adaptimmune Therapeutics PLC
--
--
--
-66.42%
64.94%
-13.92%
-79.13%
349.2%
-30.43%
-61.07%
-26.03%
S&P 500 Total Return
32.39%
13.69%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
12.37%
Akari Therapeutics PLC
--
-32.39%
-69.79%
-51.45%
-38.49%
-63.74%
11.46%
5.71%
-18.92%
-68.67%
-65.50%
NuCana PLC
--
--
--
--
--
43.42%
-57.93%
-26.39%
-46.99%
-72.27%
27.27%
Mereo BioPharma Group PLC
--
--
--
--
--
--
--
9.15%
-55.31%
-53.12%
41.33%
DBV Technologies SA
--
--
33.89%
-3.25%
-29.97%
-73.90%
66.67%
-75.51%
-38.93%
-4.38%
30.07%
As of June 02, 2023.

Periodic Total Returns Versus Peers

Loading chart...
Name
1M
3M
6M
1Y
3Y
5Y
10Y
15Y
20Y
AT
Adaptimmune Therapeutics PLC
-21.17%
-34.15%
-47.57%
-24.48%
-55.31%
-39.60%
--
--
--
-28.37%
S&P 500 Total Return
4.17%
8.04%
6.09%
4.32%
13.39%
11.32%
12.27%
10.02%
9.88%
9.99%
Akari Therapeutics PLC
-11.18%
-50.41%
-69.91%
-85.78%
-57.75%
-39.07%
-51.76%
--
--
-51.74%
NuCana PLC
7.69%
-39.57%
1.82%
39.19%
-49.36%
-50.04%
--
--
--
-40.58%
Mereo BioPharma Group PLC
-11.67%
16.97%
26.61%
112.0%
-17.68%
--
--
--
--
-35.68%
DBV Technologies SA
31.79%
45.26%
49.62%
26.75%
-26.20%
-38.26%
--
--
--
-24.69%
As of June 02, 2023. Returns for periods of 1 year and above are annualized.

Cumulative Total Returns Versus Peers